ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study

NATerminatedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Heart Valve Diseases
Interventions
DEVICE

ATS 3f Aortic Bioprosthesis

Equine Pericardial Bioprosthesis for replacement of diseased valve

Trial Locations (6)

10032

Columbia University, New York

19096

Main Line Health Heart Center, Wynnewood

19104

Univ of Pennsylvania Medical Center, Philadelphia

60453

Cardiac Surgery Clinical Research Center, Inc., Oak Lawn

75226

Baylor University, Dallas

H3A 1A1

McGill University Health Center, Montreal

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY

NCT01116037 - ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study | Biotech Hunter | Biotech Hunter